SCHEMBL2009227

SCHEMBL2009227

O=C(c1nnc(-c2cccnc2)o1)c1c(C(F)(F)F)n(Cc2ccc(Cl)cc2)c2ccccc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
RAB9A P51151 3/20 0.42
NPC1 O15118 3/20 0.42
FAAH O00519 1/20 0.42
CES1 P23141 1/20 0.42
L3MBTL1 Q9Y468 2/20 0.40
PTGES2 Q9H7Z7 1/20 0.40
HDAC6 Q9UBN7 3/20 0.39
LMNA P02545 4/20 0.39
MAPK1 P28482 2/20 0.39
KDM4E B2RXH2 4/20 0.37
ALDH1A1 P00352 3/20 0.37
MAPT P10636 2/20 0.37
MITF O75030 1/20 0.37
HPGD P15428 1/20 0.37
ALOX15 P16050 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2004532 0.92 PTGES2 (0.42) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL2006816 0.91 LMNA (0.42) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL2005876 0.91 LMNA (0.50) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL2003185 0.90 PTGES2 (0.41) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL2005834 0.90 LMNA (0.39) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL2008741 0.90 PTGES2 (0.44) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL2007614 0.89 PTGES2 (0.41) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL1999932 0.89 RAB9A (0.46) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL2002122 0.88 PTGES2 (0.41) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL2003170 0.88 RAB9A (0.45) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7960544-B2 Useful indole compounds IRONWOOD PHARMACEUTICALS, INC. (US) 2011-06-14 US disclosed
US-20090264653-A1 USEFUL INDOLE COMPOUNDS IRONWOOD PHARMACEUTICALS, INC. 2009-10-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090264653-A1 USEFUL INDOLE COMPOUNDS FAAH, FAAH2, AANAT CYP1A2 360/4885CYP3A4 618/4885CYP2D6 361/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.